| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |